Enhanced Implantable and Non-Invasive Stimulators for Gastrointestinal Therapeutics

An improved system for gastrointestinal therapeutics, offering miniaturized implantable devices and non-invasive transcutaneous stimulation systems, enhancing treatment efficacy, safety, and patient comfort.

The original patent disclosed a system for gastrointestinal therapeutics using implantable and non-invasive stimulators. However, the existing system had limitations, such as bulkiness, limited sensing capabilities, and lack of personalized treatment options. The new inventive concept addresses these limitations by introducing miniaturized implantable devices, advanced sensing capabilities, and personalized treatment options, providing a more efficient, safe, and effective solution for gastrointestinal therapeutics.

The new inventive concept comprises a miniaturized implantable device configured to provide electrical stimulation to the gastrointestinal (GI) tract through direct stimulation on enteric nervous system/ICCs or the cercial and celiac branches of the vagus nerve. The device further includes advanced sensors, such as pH and pressure sensors, to monitor the GI tract. Additionally, the system includes a non-invasive, transcutaneous stimulation system, comprising a wearable device with an array of independently addressable electrodes and a mobile device configured to deliver instructions to the wearable device. The system also enables personalized treatment options, including monitoring food intake and calorie consumption, and providing recommendations for improving GI health.

The new inventive concept introduces several novel and non-obvious features, including the miniaturized implantable device, advanced sensing capabilities, and personalized treatment options. These features provide a significant improvement over the existing system, enabling more efficient, safe, and effective treatment of gastrointestinal disorders.

Alternative embodiments of the inventive concept may include variations in the design and configuration of the miniaturized implantable device, such as different shapes, sizes, and materials. Additionally, the system may be adapted for use in different applications, such as treating obesity or expediting healing of the bowel after surgery.

The enhanced implantable and non-invasive stimulators for gastrointestinal therapeutics have significant commercial potential in the healthcare industry, particularly in the areas of gastroenterology, obesity treatment, and post-surgical care. The market for gastrointestinal therapeutics is expected to grow significantly in the coming years, driven by the increasing prevalence of gastrointestinal disorders and the need for more effective and safe treatment options.